First Horizon Names Jeffrey R. Balser, M.D.
Dr. Balser is the President, Chief Executive Officer and a member of the board of directors of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine. MEMPHIS, Tenn.
Fiscal Year: January - December
First Horizon Corporation (FHN), listed on the NYSE, has a market capitalization of $11.02B. As of Oct 31, 2026, the stock is trading at $23.27 per share@else an unavailable price , offering investors a clear view of its current market value. First Horizon Corporation is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 16.65, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. First Horizon Corporation also offers a dividend yield of 2.92%, making it an attractive option for income-focused investors who seek regular dividends.
DCF analysis data is not yet available for First Horizon Corporation (FHN). A fair value is shown for companies with at least three years of reported free cash flow and a positive typical free cash flow margin. Banks, insurers and REITs need a different valuation model and are not covered yet.
The proprietary SS Score for First Horizon Corporation is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for First Horizon Corporation, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for First Horizon Corporation is 10.84, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, First Horizon Corporation (FHN) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether First Horizon Corporation (FHN) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. It is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of First Horizon Corporation (FHN) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of First Horizon Corporation. To access the full SS Score, consider upgrading your subscription.
First Horizon Corporation is a significant player in the industry sector, with a market capitalization of $11.02B and a competitive P/E ratio of 16.65. Investors should compare these metrics with industry peers to gauge whether First Horizon Corporation is outperforming or underperforming within its sector.
Dr. Balser is the President, Chief Executive Officer and a member of the board of directors of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine. MEMPHIS, Tenn.
MEMPHIS, Tenn., Oct. 26, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) (or "First Horizon") today announced that its board of directors declared a quarterly cash dividend of $0.17 per sha...
MEMPHIS, Tenn., Oct. 26, 2026 /PRNewswire/ -- First Horizon Bank (NYSE: FHN) (or "First Horizon") is pleased to announce that Dwayne "DJ" Mercadel has joined the First Horizon team as its Gulf States ...
MEMPHIS, Tenn., Oct. 21, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) today announced Chief Financial Officer Hope Dmuchowski will participate in the BancAnalysts Association of Boston C...
MEMPHIS, Tenn., Oct. 21, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) (or "First Horizon") is pleased to announce that Lena McCloskey, Senior Vice President, Head of Banking Quality and...
MEMPHIS, Tenn., Oct. 20, 2026 /PRNewswire/ -- First Horizon Bank (NYSE: FHN) (or "First Horizon") today announced a partnership with Greenlight Financial Technology, Inc. ("Greenlight") to give First ...
MEMPHIS, Tenn., Oct. 19, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) (or "First Horizon") is pleased to announce that Senior Executive Vice President and Chief Operating Officer Tammy ...
Truist raised the firm’s price target on First Horizon (FHN) to $26 from $25 and keeps a Hold rating on the shares. The firm is adjusting its model after the…
Raymond James lowered the firm’s price target on First Horizon (FHN) to $27 from $28 and keeps an Outperform rating on the shares. Despite mixed Q3 results with weaker underlying…
Morgan Stanley raised the firm’s price target on First Horizon (FHN) to $31 from $30 and keeps an Equal Weight rating on the shares. The sale of $4.5B of low…
JPMorgan lowered the firm’s price target on First Horizon (FHN) to $26 from $27 and keeps a Neutral rating on the shares. The firm updated the company’s model post the…
First Horizon (FHN) disclosed in its earnings release that it entered into an agreement in early October to sell $4.5B of “select lower yielding” consumer mortgages. The transaction will be…
“This quarter’s results are a testament to our disciplined approach and clear strategic priorities,” said Bryan Jordan, chairman, president and CEO of First Horizon (FHN) Corporation. “Average client ...
MEMPHIS, Tenn., Oct. 15, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) (or "First Horizon") today reported financial results for the third quarter of a net loss available to common shareh...
First Horizon CFO Recognized for the Third Consecutive Year MEMPHIS, Tenn., Oct. 9, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN or "First Horizon") is pleased to announce that Senior Exe...
Truist lowered the firm’s price target on First Horizon (FHN) to $25 from $27 and keeps a Hold rating on the shares as part of a broader research note previewing…
TD Cowen lowered the firm’s price target on First Horizon (FHN) to $26 from $27 and keeps a Hold rating on the shares. The firm adjusted targets in the mid-cap…
Evercore ISI analyst John Pancari lowered the firm’s price target on First Horizon (FHN) to $25 from $26 and keeps an In Line rating on the shares. The firm expects…
Wells Fargo analyst Terry McEvoy lowered the firm’s price target on First Horizon (FHN) to $25 from $28 and keeps an Equal Weight rating on the shares. The firm remains…
MEMPHIS, Tenn., Sept. 24, 2026 /PRNewswire/ -- First Horizon (NYSE: FHN) is pleased to congratulate Tanya Hart, Senior Executive Vice President and Chief Human Resources Officer, on being named the 20...
MEMPHIS, Tenn., Sept. 22, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) plans to announce third quarter financial results on October 15, 2026.
Citi analyst Benjamin Gerlinger lowered the firm’s price target on First Horizon (FHN) to $28 from $28.50 and keeps a Buy rating on the shares. The firm updated bank models…
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.